Speakers

Dzihan Abazovic, is a physician and researcher working in the field of regenerative medicine, cellular and subcellular therapies, and longevity medicine. His work focuses on the clinical and translational application of advanced regenerative technologies including bone marrow aspirate concentrate (BMAC), platelet‑rich plasma (PRP), exosome‑based therapies, mitochondrial transfer, and blood purification protocols. He actively participates in international scientific congresses and collaborations focused on the integration of regenerative medicine into preventive and longevity‑oriented healthcare models.

He graduated from Ankara University, Faculty of Pharmacy in 1987 with honors. He had Master of Science degree in 1992 and Ph.D. Degree in 1997 at the Department of Toxicology at Gülhane Military Medical Academy. He became Associate Professor in Toxicology in 1999 and Professor in 2008. He represented Turkish Army in NATO Working Group on Military Medical Material and Military Pharmacy for 10 years. He started his new career at Yeditepe University in 2010. He became Vice Rector for Yeditepe University between 2012-2024. He has above 189 research paper published at international journals. He has also poster and oral presentations at different congress. His papers were cited above 3900 times. His H index is 37. He conducted a lot of research projects. His main research topics are oxidative stress, heavy metal toxicity, risk assessment, biocompatibility tests for medical devices and safety evaluation of drugs and medical devices. He teaches Toxicology at Faculty of Pharmacy. He is a member of Turkish Society of Toxicology and EUROTOX. He has rights and honors of European Registered Toxicologist (ERT). Actually he works for Yeditepe University as Head of Department of Toxicology and Director of Yeditepe University, Faculty of Pharmacy Drug, Cosmetic and Medical Device R&D Laboratory (YEUF-İKTAL).

Christopher H. Evans, PhD, DSc, is the John and Posy Krehbiel Professor of Orthopedics at the Mayo Clinic, with the academic rank of Professor of Physical Medicine and Rehabilitation, Orthopedic Surgery and Molecular Medicine in the Mayo Clinic College of Medicine and Science.

Dr. Evans earned BSc, PhD and DSc degrees in genetics, microbiology and biochemistry at the University of Wales, United Kingdom. He completed a postdoctoral fellowship in molecular biology at Free University of Brussels, Belgium and earned a MA in the history and philosophy of science at the University of Pittsburgh. He has an honorary MA from Harvard Medical School, where he is the Maurice Müller Professor of Orthopaedic Surgery Emeritus.

A former President of the Orthopaedic Research Society, Dr. Evans is a fellow of the Royal Society of Chemistry, the Royal College of Pathologists, the Orthopaedic Research Society, International Orthopaedic Research and the Learned Society of Wales. He is also an honorary member of the Croatian Orthopaedic Society and an honorary fellow of Swansea University. He has won a number of awards, most recently the 2025 Outstanding Achievement in Mentoring Award from the Orthopaedic Research Society. He is a co-founder of the arthritis gene therapy company Genascence Corp.

Manuela E. Gomes is a Full Professor of Bioengineering at the Institute for Medical and Biomedical Sciences (ICBAS), University of Porto, and leads the Regenerative Medicine & 3D Tissue Modelling research group at UMIB (ICBAS). Her research focuses on tissue engineering and regenerative medicine, including magnetic‑stimulus strategies to develop anisotropic scaffolds and bioinks that guide stem‑cell differentiation and modulate inflammation—particularly for tendon regeneration—and related approaches for musculoskeletal tumour modelling.

She has coordinated and contributed to numerous European and national projects (including an ERC Consolidator Grant), and has mentored a broad cohort of trainees (27 MSc, 23 PhD, and 22 post‑doctoral researchers). She has authored ~250 peer‑reviewed journal papers, 47 book chapters, edited multiple reference works, and is co‑author of 9 patent families, with extensive invited lectures and conference communications. Her publications have received 12,000+ citations (Web of Science h‑index 62; Google Scholar h‑index 80).

She currently serves as Chair of TERMIS‑EU (European Chapter) and is Ambassador to Portugal of the European Orthopaedic Research Society (EORS). ORCID: 0000‑0002‑2036‑6291.

It will be uploaded soon

It will be uploaded soon

Prof. Reha Ş. Kişnişci completed his DDS at Ankara University Faculty of Dentistry (1979–1984) and earned his PhD in Clinical Sciences at the same institution (1984–1987). His doctoral thesis investigated experimentally applied inverted dermal grafts for intraoral defects, including clinical, histopathological, and electron‑microscopic evaluations.

He has served in academic leadership and senior faculty roles for decades, including Professor at Ankara University Faculty of Dentistry (1997–2021). He is currently Professor at Lokman Hekim University Faculty of Dentistry, Department of Clinical Sciences (2021–present), where he also serves as Head of Department / Division.

Bahattin Koc is a Professor of Faculty of Engineering and Natural Sciences at Sabancı University. His research spans 3D bioprinting, computational biomodelling, nano/micro-scale manufacturing and, additive manufacturing. He has published over 100 papers, holds three patents, and has received major honors including the Elginkan Foundation Science and Technology Award, the Turkish Heart Association Award, and the Marie Curie Career Integration Award, with research funding exceeding million.

Julietta V. Rau (Dr., PhD) is Director of Research and head of a laboratory and research group at the Institute of the Structure of Matter of the Italian National Research Council (ISM-CNR, Rome, Italy). She has authored 240+ peer‑reviewed journal articles, delivered ~200 conference presentations, and given 45 invited/plenary/keynote talks, and holds 3 international patents (h‑index 48; ~7,000 citations on Google Scholar).

She has received multiple international awards and serves as Chair and organizer of the biennial BioMaH “Biomaterials for Healthcare” International Conference. She is also an Ambassador for Italy at the European Orthopaedic Research Society and an Honorary Member of the Romanian Society for Biomaterials.

Her editorial roles include Associate Editor (Bioactive Materials; Frontiers in Biomaterials Science) and Editorial Board Member for several journals. Her current research focuses on innovative biomaterials for regenerative medicine, orthopaedics and dentistry—especially calcium phosphates and bioactive glasses for tissue engineering—along with antibacterial implant surfaces, novel imaging approaches for cancer diagnostics, and biodegradable alloys/coatings.

Dr. Yasuhiko Tabata is Professor Emeritus at Kyoto University and Special Professor leading the Cell Biotechnology Group in the Department of Plastic and Reconstructive Surgery, Graduate School of Medicine.

He received his degrees in polymer chemistry, technology, medical science, and pharmaceutical science from Kyoto University and was a visiting scientist at the Massachusetts Institute of Technology (MIT) under Prof. Robert Langer. He is an internationally recognized researcher in biomaterials and regenerative medicine, with more than 1,700 scientific publications and over 140 patents. His interdisciplinary work integrates polymer chemistry, pharmaceutical sciences, biology, and clinical medicine, focusing on biomaterials design, drug delivery systems, tissue engineering, stem cell technology, and translational regenerative therapies.

Prof. Tabata has received numerous prestigious national and international awards and has held leadership roles in major scientific societies, including the Tissue Engineering and Regenerative Medicine International Society (TERMIS-AP) and the Japan Society of Drug Delivery System. He has actively contributed to advancing translational research by fostering collaborations between academia, clinical practice, and industry to develop innovative regenerative medicine strategies and biomedical applications.